HK1220459A1 - 激酶抑制劑 - Google Patents
激酶抑制劑Info
- Publication number
- HK1220459A1 HK1220459A1 HK16108561.4A HK16108561A HK1220459A1 HK 1220459 A1 HK1220459 A1 HK 1220459A1 HK 16108561 A HK16108561 A HK 16108561A HK 1220459 A1 HK1220459 A1 HK 1220459A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- kinase inhibitors
- kinase
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/02—Formic acid
- C07C53/06—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13170937 | 2013-06-06 | ||
PCT/EP2014/061683 WO2014195402A1 (en) | 2013-06-06 | 2014-06-05 | Kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1220459A1 true HK1220459A1 (zh) | 2017-05-05 |
Family
ID=48569997
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16108561.4A HK1220459A1 (zh) | 2013-06-06 | 2016-07-19 | 激酶抑制劑 |
Country Status (10)
Country | Link |
---|---|
US (2) | US9181242B2 (zh) |
EP (1) | EP3004097B1 (zh) |
KR (1) | KR20160018567A (zh) |
CN (1) | CN105377847A (zh) |
AR (1) | AR096532A1 (zh) |
BR (1) | BR112015029970A2 (zh) |
CA (1) | CA2914432A1 (zh) |
HK (1) | HK1220459A1 (zh) |
RU (1) | RU2015151886A (zh) |
WO (1) | WO2014195402A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2788349T3 (en) | 2011-12-09 | 2017-01-30 | Chiesi Farm Spa | kinase inhibitors |
CN105377847A (zh) * | 2013-06-06 | 2016-03-02 | 奇斯药制品公司 | 激酶抑制剂 |
KR20160015221A (ko) * | 2013-06-06 | 2016-02-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
BR112015029504A2 (pt) * | 2013-06-06 | 2017-07-25 | Chiesi Farm Spa | inibidores quinase |
EP3394058B1 (en) | 2015-12-23 | 2020-10-14 | Chiesi Farmaceutici S.p.A. | N-[3-(3-{4-[[1,2,4]triazolo[4,3-a]pyridin-6-yloxy]-1,2,3,4-tetrahydro-naphthalen-1-yl} -ureido)-phenyl]-methanesulfonamide derivatives and their use as p38 mapk inhibitors |
TW201730189A (zh) | 2015-12-23 | 2017-09-01 | 吉斯藥品公司 | 激酶抑制劑 |
US10364245B2 (en) | 2017-06-07 | 2019-07-30 | Chiesi Farmaceutici S.P.A. | Kinase inhibitors |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
CN108424372B (zh) * | 2018-05-11 | 2021-08-10 | 浙江华贝药业有限责任公司 | 2,2,2-三氟-n-[(s)-4-羰基四氢萘-1-基]-乙酰胺的纯化工艺 |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
WO2020113094A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
US11427567B2 (en) | 2019-08-14 | 2022-08-30 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors |
KR20220099970A (ko) | 2019-10-11 | 2022-07-14 | 인사이트 코포레이션 | Cdk2 억제제로서의 이환식 아민 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU650953B2 (en) | 1991-03-21 | 1994-07-07 | Novartis Ag | Inhaler |
WO1997002289A1 (en) | 1995-07-06 | 1997-01-23 | Zeneca Limited | Peptide inhibitors of fibronectine |
US6248713B1 (en) | 1995-07-11 | 2001-06-19 | Biogen, Inc. | Cell adhesion inhibitors |
YU25500A (sh) | 1999-05-11 | 2003-08-29 | Pfizer Products Inc. | Postupak za sintezu analoga nukleozida |
GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
EP1241176A1 (en) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Purine derivatives for the treatment of ischemia |
EP1458682B1 (en) | 2001-12-20 | 2006-08-30 | Bayer HealthCare AG | 1,4-dihydro-1,4-diphenylpyridine derivatives |
WO2004072072A1 (en) | 2003-02-14 | 2004-08-26 | Pfizer Products Inc. | Triazolo-pyridines as anti-inflammatory compounds |
SE0302487D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
RU2373197C2 (ru) * | 2004-03-30 | 2009-11-20 | Тайсо Фармасьютикал Ко., Лтд. | Пиримидиновые производные, обладающие активностью в отношении мсн |
EP1609789A1 (en) | 2004-06-23 | 2005-12-28 | Eli Lilly And Company | Ureido-pyrazole derivatives and their use as kinase inhibitors |
ES2308523T3 (es) | 2004-06-23 | 2008-12-01 | Eli Lilly And Company | Inhibidores de quinasa. |
EP1781655A2 (en) | 2004-08-18 | 2007-05-09 | Pharmacia & Upjohn Company LLC | Triazolopyridine compounds useful for the treatment of inflammation |
GB0502258D0 (en) | 2005-02-03 | 2005-03-09 | Argenta Discovery Ltd | Compounds and their use |
JP2008545756A (ja) | 2005-06-03 | 2008-12-18 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 癌化学療法剤として有用な1−メチル−1h−ピラゾール−4−カルボキサミド類 |
CA2642209A1 (en) | 2006-02-09 | 2007-08-16 | Pfizer Limited | Triazolopyridine compounds |
US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
AR063141A1 (es) | 2006-10-04 | 2008-12-30 | Pharmacopeia Inc | Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion |
CA2665214A1 (en) | 2006-10-06 | 2008-05-29 | Abbott Laboratories | Novel imidazothiazoles and imidazoxazoles |
WO2008125014A1 (fr) | 2007-04-13 | 2008-10-23 | Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. | Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques |
CA2695636A1 (en) | 2007-08-10 | 2009-02-19 | Astellas Pharma Inc. | Bicyclic acylguanidine derivative |
TWI496779B (zh) | 2008-08-19 | 2015-08-21 | Array Biopharma Inc | 作為pim激酶抑制劑之三唑吡啶化合物 |
JP5696052B2 (ja) | 2008-12-08 | 2015-04-08 | ギリアード コネチカット, インコーポレイテッド | イミダゾピラジンsyk阻害剤 |
WO2010077836A2 (en) | 2009-01-05 | 2010-07-08 | Boehringer Ingelheim International Gmbh | Pyrrolidine compounds which modulate the cb2 receptor |
WO2010094956A1 (en) * | 2009-02-17 | 2010-08-26 | Pulmagen Therapeutics (Inflammation) Limited. | Triazolopyridine derivatives as p38 map kinase inhibitors |
GB0902648D0 (en) | 2009-02-17 | 2009-04-01 | Argenta Discovery Ltd | Pharmaceutical compounds and compositions |
WO2010108058A2 (en) | 2009-03-20 | 2010-09-23 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Small molecule inhibitors of dusp6 and uses therefor |
WO2011018916A1 (ja) | 2009-08-12 | 2011-02-17 | コニカミノルタホールディングス株式会社 | 表示パネルの製造方法 |
EP2308866A1 (de) | 2009-10-09 | 2011-04-13 | Bayer CropScience AG | Phenylpyri(mi)dinylpyrazole und ihre Verwendung als Fungizide |
GB2481022B (en) | 2010-06-08 | 2014-10-08 | Dean Bowie | Anchor apparatus |
GB201009731D0 (en) | 2010-06-10 | 2010-07-21 | Pulmagen Therapeutics Inflamma | Kinase inhibitors |
KR20140103925A (ko) | 2011-12-09 | 2014-08-27 | 키에시 파르마슈티시 엣스. 피. 에이. | 4-히드록시-1,2,3,4-테트라히드로나프탈렌-1-일 우레아 및 호흡기 질환의 치료에서의 이들의 용도 |
DK2788349T3 (en) * | 2011-12-09 | 2017-01-30 | Chiesi Farm Spa | kinase inhibitors |
SG11201402986RA (en) * | 2011-12-09 | 2014-12-30 | Chiesi Farma Spa | Kinase inhibitors |
CN105377847A (zh) * | 2013-06-06 | 2016-03-02 | 奇斯药制品公司 | 激酶抑制剂 |
KR20160015221A (ko) | 2013-06-06 | 2016-02-12 | 키에시 파르마슈티시 엣스. 피. 에이. | 키나아제 억제제 |
-
2014
- 2014-06-05 CN CN201480032047.4A patent/CN105377847A/zh active Pending
- 2014-06-05 AR ARP140102194A patent/AR096532A1/es unknown
- 2014-06-05 CA CA2914432A patent/CA2914432A1/en not_active Abandoned
- 2014-06-05 EP EP14732835.5A patent/EP3004097B1/en active Active
- 2014-06-05 WO PCT/EP2014/061683 patent/WO2014195402A1/en active Application Filing
- 2014-06-05 BR BR112015029970A patent/BR112015029970A2/pt not_active IP Right Cessation
- 2014-06-05 US US14/296,794 patent/US9181242B2/en not_active Expired - Fee Related
- 2014-06-05 KR KR1020157035849A patent/KR20160018567A/ko not_active Application Discontinuation
- 2014-06-05 RU RU2015151886A patent/RU2015151886A/ru not_active Application Discontinuation
-
2015
- 2015-09-29 US US14/868,516 patent/US9440974B2/en active Active
-
2016
- 2016-07-19 HK HK16108561.4A patent/HK1220459A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3004097A1 (en) | 2016-04-13 |
CN105377847A (zh) | 2016-03-02 |
KR20160018567A (ko) | 2016-02-17 |
RU2015151886A3 (zh) | 2018-03-30 |
US9181242B2 (en) | 2015-11-10 |
US20140364412A1 (en) | 2014-12-11 |
CA2914432A1 (en) | 2014-12-11 |
EP3004097B1 (en) | 2018-01-17 |
BR112015029970A2 (pt) | 2017-07-25 |
AR096532A1 (es) | 2016-01-13 |
US9440974B2 (en) | 2016-09-13 |
WO2014195402A1 (en) | 2014-12-11 |
RU2015151886A (ru) | 2017-06-08 |
US20160016953A1 (en) | 2016-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1220459A1 (zh) | 激酶抑制劑 | |
HK1217198A1 (zh) | 蛋白激酶抑制劑 | |
HK1226073A1 (zh) | 凋亡信號調節激酶的抑制劑 | |
ZA201603337B (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
HK1225735A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
HK1211578A1 (zh) | 作為 激酶抑制劑的酰氨基咪唑並噠嗪 | |
HK1223877A1 (zh) | 絲氨酸/蘇氨酸激酶抑制劑 | |
HK1214813A1 (zh) | 激酶抑制劑 | |
HK1219104A1 (zh) | 激酶抑制劑 | |
HK1218119A1 (zh) | 蛋白激酶抑制劑 | |
HK1216531A1 (zh) | 新的抑制劑 | |
EP3007689A4 (en) | NON-SELECTIVE KINASE INHIBITORS | |
ZA201604461B (en) | Serine/threonine kinase inhibitors | |
EP2968358A4 (en) | NOVEL CHOLINKINASE INHIBITORS | |
HK1222539A1 (zh) | 激酶抑制劑組合 | |
EP2999472A4 (en) | INHIBITORS OF AURORA KINASE | |
IL244029B (en) | Deoxycytodine kinase inhibitors | |
GB201307155D0 (en) | Kinase inhibitors | |
GB201323021D0 (en) | Use of kinase inhibitors | |
GB201321227D0 (en) | Use of kinase inhibitors | |
GB201305503D0 (en) | Inhibitor | |
GB201300087D0 (en) | Dram |